USPH
The good news: people are showing up
U.S. Physical Therapy’s second quarter had a pretty simple headline: more patients, more revenue, more momentum. The company said revenue grew thanks to higher patient volumes and improved reimbursement rates — the kind of combo that makes an outpatient business look a lot healthier than your average gym membership renewal cycle.
The not-so-fun part: costs are doing the backstroke
Of course, every good earnings story needs a villain, and this one showed up wearing a lab coat and a staffing badge. Elevated employee healthcare claims and upfront staffing costs squeezed results, reminding you that growth is great until expenses decide to join the party uninvited.
Why investors should care
The interesting wrinkle here is the early rollout of hospital-affiliation agreements. That could be a meaningful growth lever if it keeps feeding new patient volume and referrals. But if claims and labor costs stay sticky, the market may care less about the top-line pop and more about whether margins can actually keep up.
Big picture: USPH still looks like a business with solid demand, but investors will want proof that volume growth can outrun the cost creep before they start handing out victory laps.